Gary Landreth
PhD
Location
Bloomington, IN, USA
Current Organization
Indiana University
Grants
Alzheimer's Disease Research
Is the Niacin Receptor HCAR2 Protective in Alzheimer's Disease?
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Miguel Moutinho, PharmD, PhD
Current Organization
Indiana University
Is the Niacin Receptor HCAR2 Protective in Alzheimer's Disease?
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Miguel Moutinho, PharmD, PhD
Current Organization
Indiana University
Alzheimer's Disease Research
RXR: A Therapeutic Target in Neurodegenerative Disease
Active Dates
July 01, 2011 - June 30, 2013
Principal Investigator
Gary Landreth, PhD
Current Organization
Indiana University
RXR: A Therapeutic Target in Neurodegenerative Disease
Active Dates
July 01, 2011 - June 30, 2013
Principal Investigator
Gary Landreth, PhD
Current Organization
Indiana University
Alzheimer's Disease Research
PPAR-Gamma as a Therapeutic Target in Alzheimer's Disease
Active Dates
April 01, 2007 - March 31, 2008
Principal Investigator
Gary Landreth, PhD
Current Organization
Indiana University
PPAR-Gamma as a Therapeutic Target in Alzheimer's Disease
Active Dates
April 01, 2007 - March 31, 2008
Principal Investigator
Gary Landreth, PhD
Current Organization
Indiana University
Alzheimer's Disease Research
Biological Functions of the Amyloid Precursor Protein
Active Dates
April 01, 1994 - March 31, 1996
Principal Investigator
Gary Landreth, PhD
Current Organization
Indiana University
Biological Functions of the Amyloid Precursor Protein
Active Dates
April 01, 1994 - March 31, 1996
Principal Investigator
Gary Landreth, PhD
Current Organization
Indiana University